BioCentury
ARTICLE | Financial News

Sienna proposes NASDAQ listing

July 3, 2017 10:20 PM UTC

Dermatology company Sienna Biopharmaceuticals Inc. (Westlake Village, Calif.) proposed to raise up to $74.8 million in an IPO on NASDAQ underwritten by JPMorgan, Cowen and BMO Capital Markets...

BCIQ Company Profiles

Sienna Biopharmaceuticals Inc.